Journal
JOURNAL OF NEUROCHEMISTRY
Volume 126, Issue 6, Pages 699-704Publisher
WILEY
DOI: 10.1111/jnc.12326
Keywords
amyotrophic lateral sclerosis; NF kappa-B; optineurin
Categories
Funding
- Japan Society for the Promotion of Science [24300132]
- Grants-in-Aid for Scientific Research [23591246, 24591259] Funding Source: KAKEN
Ask authors/readers for more resources
Mutations in more than 10 genes are reported to cause familial amyotrophic lateral sclerosis (ALS). Among these genes, optineurin (OPTN) is virtually the only gene that is considered to cause classical ALS by a loss-of-function mutation. Wildtype optineurin (OPTNWT) suppresses nuclear factor-kappa B (NF-kappa B) activity, but the ALS-causing mutant OPTN is unable to suppress NF-kappa B activity. Therefore, we knocked down OPTN in neuronal cells and examined the resulting NF-kappa B activity and phenotype. First, we confirmed the loss of the endogenous OPTN expression after siRNA treatment and found that NF-kappa B activity was increased in OPTN-knockdown cells. Next, we found that OPTN knockdown caused neuronal cell death. Then, overexpression of OPTNWT or OPTNE50K with intact NF-kappa B-suppressive activity, but not overexpression of ALS-related OPTN mutants, suppressed the neuronal death induced by OPTN knockdown. This neuronal cell death was inhibited by withaferin A, which selectively inhibits NF-kappa B activation. Lastly, involvement of the mitochondrial proapoptotic pathway was suggested for neuronal death induced by OPTN knockdown. Taken together, these results indicate that inappropriate NF-kappa B activation is the pathogenic mechanism underlying OPTN mutation-related ALS.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available